{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:03:36Z","timestamp":1763125416226,"version":"3.45.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    A 64-year-old woman with persistent headaches and vision disturbances underwent\n                    <jats:sup>18<\/jats:sup>\n                    F-(2S,4R)-4-fluoroglutamine (\n                    <jats:sup>18<\/jats:sup>\n                    F-FGln) PET\/CT due to MRI contraindications. Imaging revealed a sellar mass with high radiotracer uptake (SUVmax 7.17), later confirmed as a WHO grade I meningioma. This case highlights the potential of\n                    <jats:sup>18<\/jats:sup>\n                    F-FGln PET\/CT in detecting meningiomas, leveraging their glutamine metabolism. Given the tumor\u2019s metabolic profile, glutaminase inhibitors may offer novel therapeutic avenues. Further research is warranted to explore the mechanistic basis of\n                    <jats:sup>18<\/jats:sup>\n                    F-FGln uptake in meningiomas and its implications for diagnosis and treatment.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006080","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T14:00:24Z","timestamp":1757685624000},"page":"1190-1191","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["18F-FGln PET\/CT Imaging Shows High Uptake in Meningiomas Providing Insights for Diagnosis and Treatment"],"prefix":"10.1097","volume":"50","author":[{"given":"Xiaoxia","family":"Xu","sequence":"first","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute"},{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"R1-20251114","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2967\/jnumed.111.093815","article-title":"PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine","volume":"52","author":"Lieberman","year":"2011","journal-title":"J Nucl Med"},{"key":"R2-20251114","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RLU.0000000000005581","article-title":"Clinical value of 18 F-(2S,4R)-4-fluoroglutamine PET\/CT in glioma","volume":"50","author":"Xu","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R3-20251114","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2967\/jnumed.116.182345","article-title":"Metabolic imaging of glutamine in cancer","volume":"58","author":"Zhu","year":"2017","journal-title":"J Nucl Med"},{"key":"R4-20251114","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"R5-20251114","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas","volume":"363","author":"Whittle","year":"2004","journal-title":"Lancet"},{"key":"R6-20251114","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","article-title":"Detection of cranial meningiomas: comparison of (6)(8)Ga-DOTATOC PET\/CT and contrast-enhanced MRI","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20251114","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/neuonc\/noab219","article-title":"Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas","volume":"24","author":"Ijare","year":"2022","journal-title":"Neuro Oncol"},{"key":"R8-20251114","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/neuonc\/noac007","article-title":"Targeting glutamine addiction in meningioma","volume":"24","author":"Tran","year":"2022","journal-title":"Neuro Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:00:58Z","timestamp":1763125258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006080","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"2025-04-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}